Galmed Pharmaceuticals Ltd (GLMD)
0.3916
0.00 (0.00%)
USD |
NASDAQ |
Apr 26, 16:00
0.3809
-0.01
(-2.73%)
After-Hours: 20:00
Galmed Pharmaceuticals Total Liabilities (Quarterly): 2.75M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.75M |
| September 30, 2023 | 2.091M |
| June 30, 2023 | 2.723M |
| March 31, 2023 | 2.801M |
| December 31, 2022 | 3.138M |
| September 30, 2022 | 5.12M |
| June 30, 2022 | 2.863M |
| March 31, 2022 | 5.83M |
| December 31, 2021 | 6.108M |
| September 30, 2021 | 6.622M |
| June 30, 2021 | 7.326M |
| March 31, 2021 | 7.42M |
| December 31, 2020 | 8.228M |
| September 30, 2020 | 6.297M |
| June 30, 2020 | 4.965M |
| March 31, 2020 | 6.335M |
| December 31, 2019 | 7.286M |
| September 30, 2019 | 3.929M |
| June 30, 2019 | 3.724M |
| March 31, 2019 | 2.908M |
| December 31, 2018 | 2.706M |
| Date | Value |
|---|---|
| September 30, 2018 | 2.139M |
| June 30, 2018 | 3.804M |
| March 31, 2018 | 2.698M |
| December 31, 2017 | 3.848M |
| September 30, 2017 | 3.145M |
| June 30, 2017 | 3.785M |
| March 31, 2017 | 4.356M |
| December 31, 2016 | 5.375M |
| September 30, 2016 | 3.934M |
| June 30, 2016 | 3.575M |
| March 31, 2016 | 3.201M |
| December 31, 2015 | 2.718M |
| September 30, 2015 | 1.513M |
| June 30, 2015 | 1.695M |
| March 31, 2015 | 1.561M |
| December 31, 2014 | 1.518M |
| September 30, 2014 | 2.933M |
| June 30, 2014 | 1.136M |
| March 31, 2014 | 1.928M |
| December 31, 2013 | 2.117M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
2.091M
Minimum
Sep 2023
8.228M
Maximum
Dec 2020
5.029M
Average
5.12M
Median
Sep 2022
Total Liabilities (Quarterly) Benchmarks
| Compugen Ltd | 55.78M |
| Pluri Inc | 34.95M |
| BioLine Rx Ltd | 50.70M |
| Can Fite Biofarma Ltd | 3.746M |
| BiomX Inc | 21.95M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 16.63M |
| Shareholders Equity (Quarterly) | 13.88M |